176 related articles for article (PubMed ID: 31394194)
21. Hes1 triggers epithelial-mesenchymal transition (EMT)-like cellular marker alterations and promotes invasion and metastasis of nasopharyngeal carcinoma by activating the PTEN/AKT pathway.
Wang SC; Lin XL; Wang HY; Qin YJ; Chen L; Li J; Jia JS; Shen HF; Yang S; Xie RY; Wei F; Gao F; Rong XX; Yang J; Zhao WT; Zhang TT; Shi JW; Yao KT; Luo WR; Sun Y; Xiao D
Oncotarget; 2015 Nov; 6(34):36713-30. PubMed ID: 26452025
[TBL] [Abstract][Full Text] [Related]
22. Targeting FoxM1 inhibits proliferation, invasion and migration of nasopharyngeal carcinoma through the epithelial‑to-mesenchymal transition pathway.
Yu C; Chen L; Yie L; Wei L; Wen T; Liu Y; Chen H
Oncol Rep; 2015 May; 33(5):2402-10. PubMed ID: 25738652
[TBL] [Abstract][Full Text] [Related]
23. [Long non-coding RNA colon cancer associated transcript-2 from nasopharyngeal carcinoma-derived exosomes promotes angiogenesis].
Zhou SK; Gao F; Zhong ZS; Yao H
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2020 Oct; 55(10):944-951. PubMed ID: 33036509
[No Abstract] [Full Text] [Related]
24. Epithelial cell adhesion molecule overexpression regulates epithelial-mesenchymal transition, stemness and metastasis of nasopharyngeal carcinoma cells via the PTEN/AKT/mTOR pathway.
Wang MH; Sun R; Zhou XM; Zhang MY; Lu JB; Yang Y; Zeng LS; Yang XZ; Shi L; Xiao RW; Wang HY; Mai SJ
Cell Death Dis; 2018 Jan; 9(1):2. PubMed ID: 29305578
[TBL] [Abstract][Full Text] [Related]
25. Exosomal miR-9 inhibits angiogenesis by targeting MDK and regulating PDK/AKT pathway in nasopharyngeal carcinoma.
Lu J; Liu QH; Wang F; Tan JJ; Deng YQ; Peng XH; Liu X; Zhang B; Xu X; Li XP
J Exp Clin Cancer Res; 2018 Jul; 37(1):147. PubMed ID: 30001734
[TBL] [Abstract][Full Text] [Related]
26. SOX10 induces epithelial-mesenchymal transition and contributes to nasopharyngeal carcinoma progression.
He P; Jin X
Biochem Cell Biol; 2018 Jun; 96(3):326-331. PubMed ID: 29035684
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of Exosome Release Sensitizes U937 Cells to PEGylated Liposomal Doxorubicin.
Hekmatirad S; Moloudizargari M; Moghadamnia AA; Kazemi S; Mohammadnia-Afrouzi M; Baeeri M; Moradkhani F; Asghari MH
Front Immunol; 2021; 12():692654. PubMed ID: 34149737
[TBL] [Abstract][Full Text] [Related]
28. MiRNA-34a reversed TGF-β-induced epithelial-mesenchymal transition via suppression of SMAD4 in NPC cells.
Huang G; Du MY; Zhu H; Zhang N; Lu ZW; Qian LX; Zhang W; Tian X; He X; Yin L
Biomed Pharmacother; 2018 Oct; 106():217-224. PubMed ID: 29960168
[TBL] [Abstract][Full Text] [Related]
29. SHROOM2 inhibits tumor metastasis through RhoA-ROCK pathway-dependent and -independent mechanisms in nasopharyngeal carcinoma.
Yuan J; Chen L; Xiao J; Qi XK; Zhang J; Li X; Wang Z; Lian YF; Xiang T; Zhang Y; Chen MY; Bei JX; Zeng YX; Feng L
Cell Death Dis; 2019 Jan; 10(2):58. PubMed ID: 30683844
[TBL] [Abstract][Full Text] [Related]
30. Accelerated growth of B16BL6 tumor in mice through efficient uptake of their own exosomes by B16BL6 cells.
Matsumoto A; Takahashi Y; Nishikawa M; Sano K; Morishita M; Charoenviriyakul C; Saji H; Takakura Y
Cancer Sci; 2017 Sep; 108(9):1803-1810. PubMed ID: 28667694
[TBL] [Abstract][Full Text] [Related]
31. EBV-miR-BART8-3p induces epithelial-mesenchymal transition and promotes metastasis of nasopharyngeal carcinoma cells through activating NF-κB and Erk1/2 pathways.
Lin C; Zong J; Lin W; Wang M; Xu Y; Zhou R; Lin S; Guo Q; Chen H; Ye Y; Zhang B; Pan J
J Exp Clin Cancer Res; 2018 Nov; 37(1):283. PubMed ID: 30477559
[TBL] [Abstract][Full Text] [Related]
32. HCC-derived exosomes elicit HCC progression and recurrence by epithelial-mesenchymal transition through MAPK/ERK signalling pathway.
Chen L; Guo P; He Y; Chen Z; Chen L; Luo Y; Qi L; Liu Y; Wu Q; Cui Y; Fang F; Zhang X; Song T; Guo H
Cell Death Dis; 2018 May; 9(5):513. PubMed ID: 29725020
[TBL] [Abstract][Full Text] [Related]
33. A directly negative interaction of miR-203 and ZEB2 modulates tumor stemness and chemotherapy resistance in nasopharyngeal carcinoma.
Jiang Q; Zhou Y; Yang H; Li L; Deng X; Cheng C; Xie Y; Luo X; Fang W; Liu Z
Oncotarget; 2016 Oct; 7(41):67288-67301. PubMed ID: 27589832
[TBL] [Abstract][Full Text] [Related]
34. Reducing NETO2 expression prevents human nasopharyngeal carcinoma (NPC) progression by suppressing metastasis and inducing apoptosis.
He AR; Zhu Q; Gao S
Biochem Biophys Res Commun; 2019 May; 513(2):494-501. PubMed ID: 30975469
[TBL] [Abstract][Full Text] [Related]
35. Exosomal DNMT1 mediates cisplatin resistance in ovarian cancer.
Cao YL; Zhuang T; Xing BH; Li N; Li Q
Cell Biochem Funct; 2017 Aug; 35(6):296-303. PubMed ID: 28791708
[TBL] [Abstract][Full Text] [Related]
36. Blocking PI3K/Akt signaling attenuates metastasis of nasopharyngeal carcinoma cells through induction of mesenchymal-epithelial reverting transition.
Jiang H; Gao M; Shen Z; Luo B; Li R; Jiang X; Ding R; Ha Y; Wang Z; Jie W
Oncol Rep; 2014 Aug; 32(2):559-66. PubMed ID: 24889918
[TBL] [Abstract][Full Text] [Related]
37. Suppression Of β-catenin Nuclear Translocation By CGP57380 Decelerates Poor Progression And Potentiates Radiation-Induced Apoptosis in Nasopharyngeal Carcinoma.
Wang W; Wen Q; Luo J; Chu S; Chen L; Xu L; Zang H; Alnemah MM; Li J; Zhou J; Fan S
Theranostics; 2017; 7(7):2134-2149. PubMed ID: 28656063
[TBL] [Abstract][Full Text] [Related]
38. The FOXM1-ABCC5 axis contributes to paclitaxel resistance in nasopharyngeal carcinoma cells.
Hou Y; Zhu Q; Li Z; Peng Y; Yu X; Yuan B; Liu Y; Liu Y; Yin L; Peng Y; Jiang Z; Li J; Xie B; Duan Y; Tan G; Gulina K; Gong Z; Sun L; Fan X; Li X
Cell Death Dis; 2017 Mar; 8(3):e2659. PubMed ID: 28277541
[TBL] [Abstract][Full Text] [Related]
39. Novel chimeric transcript RRM2-c2orf48 promotes metastasis in nasopharyngeal carcinoma.
Han P; Chen RH; Wang F; Zeng JY; Yu ST; Xu LH; Cai Q; Liang FY; Xia TL; Lin ZR; Zhong Q; Huang XM
Cell Death Dis; 2017 Sep; 8(9):e3047. PubMed ID: 28906488
[TBL] [Abstract][Full Text] [Related]
40. Upregulated TRIM29 promotes proliferation and metastasis of nasopharyngeal carcinoma via PTEN/AKT/mTOR signal pathway.
Zhou XM; Sun R; Luo DH; Sun J; Zhang MY; Wang MH; Yang Y; Wang HY; Mai SJ
Oncotarget; 2016 Mar; 7(12):13634-50. PubMed ID: 26872369
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]